新闻
ACHV
--
0.00%
--
ACHV:更长的专利,更高的估值
By John Vandermosten, CFA NASDAQ:ACHV READ THE FULL ACHV RESEARCH REPORT
Benzinga · 07/17 10:30
更新:最近在推特上发布的关于实现生命科学的 Zack SCR 报告是从 6 月 28 日开始的
https://scr.zacks.com/news/news-details/2021/ACHV-Longer-Patents-Higher-Valuation/default.aspx
Benzinga · 07/12 14:05
实现生命科学股见卷; Zacks SCR 推文报告题为“更长的专利,更高的估值”
https://twitter.com/ZacksSmallCap/status/1414585279227342851
Benzinga · 07/12 14:03
ACHV:以延长专利寿命为目标
By John Vandermosten, CFA NASDAQ:ACHV READ THE FULL ACHV RESEARCH REPORT
Benzinga · 07/07 15:27
The Daily Biotech Pulse:赛诺菲在 mRNA 技术、MediWound 决策日、DiaMedica 发布肾脏疾病数据读出方面押注大赌注
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 28)
Benzinga · 06/29 12:17
奥本海默以跑赢大盘评级,23 美元的目标价启动对 Achieve Life Sciences 的报道
MT Newswires · 06/23 10:21
昨天的54大动作
Gainers Flanigan's Enterprises, Inc. (NYSE: BDL) shares surged 40.6% to close at $34.90 on Tuesday after the company reported results for the 13 weeks and the 26 weeks ended April 3, 2021.
Benzinga · 05/26 08:55
为什么实现生命科学的股票今天交易价格较低
Achieve Life Sciences (NASDAQ:ACHV) shares are trading lower after the company priced a $20 million underwritten public offering of 2,857,143 shares of common stock at $7 per share.
Benzinga · 05/25 19:32
午后市场更新:Dycom Industries在第一季度业绩后下跌;联合公司股票幻灯片
Toward the end of trading Tuesday, the Dow traded down 0.09% to 34,362.49 while the NASDAQ fell 0.04% to 13,655.88. The S&P also fell, dropping 0.14% to 4,191.36.
Benzinga · 05/25 18:49
午盘市场更新:美股走低;美股走低。 Provention生物股价飙升
Midway through trading Tuesday, the Dow traded down 0.16% to 34,337.29 while the NASDAQ fell 0.16% to 13,638.63. The S&P also fell, dropping 0.20% to 4,188.77.
Benzinga · 05/25 16:21
周二中午交易的42只股票
Gainers SemiLEDs Corporation (NASDAQ: LEDS) shares surged 28.4% to $10.17 following reports indicating equipment billings increased 50% in April compared to the prior year's period.
Benzinga · 05/25 16:17
以19%的折扣通过股权募集2000万美元后,实现Life Sciences股票暴跌
Benzinga · 05/25 15:33
ACHV:ORCA-2的注册进展顺利
By John Vandermosten, CFA NASDAQ:ACHV READ THE FULL ACHV RESEARCH REPORT
Benzinga · 05/25 14:00
周二盘前交易中的12种医疗保健股
 
Benzinga · 05/25 12:09
周二盘前交易中的25只股票
Gainers U.S. Well Services, Inc. (NASDAQ: USWS) rose 30.5% to $1.25 in pre-market trading after the company reported commitment to becoming all-electric hydraulic facturing services provider.
Benzinga · 05/25 11:00
实现生命科学以公开发行股票
By Chris Wack Achieve Life Sciences Inc. said it is proposing an underwritten public offering in which it intends to offer and sell shares of its common...
marketwatch.com · 05/25 10:15
实现生命科学公司2000万美元的普通股发行价格
MT Newswires · 05/25 09:11
周一盘后交易中的7只股票
Gainers Scholar Rock (NASDAQ: SRRK) shares are trading higher after the company announced it received FDA Fast Track designation for apitegromab for the treatment of patients with spinal muscular atrophy.
Benzinga · 05/24 21:03
周一盘后交易时段中12支医疗保健股上涨
Gainers
Benzinga · 05/24 20:31
MT Newswires Hours监视列表:DPW,JYNT,ACHV
MT Newswires · 05/24 18:02
微牛提供丰富的实时ACHV股票新闻,让你可以通过多个平台了解ACHV股票行情最新动态,这些免费的Achieve新闻可以帮助你做出明智投资。
ACHV 简况
Achieve Life Sciences, Inc.(原名:OncoGenex Pharmaceuticals, Inc.)是一家致力于开发和商业化治疗癌症耐药性疗法的临床阶段生物制药公司。 该公司主要在加拿大和美国从事癌症疗法的开发和商业化业务。该公司的候选产品包括Custirsen、Apatorsen和OGX-225。该公司致力于靶向特定蛋白质,以阻止肿瘤细胞的适应性防御,从而使肿瘤细胞易受到一系列癌症疗法的攻击。在该公司的候选产品中,Custirsen和Apatorsen是临床阶段的资产。Custirsen正在两个第三阶段临床试验中进行评估。Apatorsen是一种旨在抑制产生热休克蛋白27(Hsp27)的候选产品。